Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.

Intellia Therapeutics Inc
Start price
€11.99
03.03.26 / 50%
Target price
€41.04
03.03.27
Performance (%)
17.65%
Price
€14.10
08:00
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 17.65%. This prediction currently runs until 03.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Intellia Therapeutics Inc 11.848% 11.848%
iShares Core DAX® 0,41 % 8,82 %
iShares Nasdaq 100 3,68 % 10,82 %
iShares Nikkei 225® 2,70 % 15,25 %
iShares S&P 500 2,44 % 7,93 %

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Intellia Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 17.65%
Target price 41.035
Change
Ends at 03.03.27

Intellia Therapeutics (NTLA) had its price target lowered by Canaccord Genuity Group Inc. from $54.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
03.03.26

Stopped prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc

buy
Intellia Therapeutics Inc

Start price
Target price
Perf. (%)
€33.50
13.04.23
€59.72
13.04.24
-29.85%
14.04.24

Canaccord Genuity Group Inc. 
13.04.23 50%